MAP2K3 and stroke disorder: Specifically, elevated miR-21 in the post-stroke brain inhibited the p38/MAPK signaling pathway by targeting MAP2K3 (MKK3), which led to reduced production of inflammatory cytokines, attenuated BBB permeability increase, and less vasogenic edema [76].